Genetic control of lithium sensitivity and regulation of inositol biosynthetic genes

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  King, Jason ^a   Keim, Melanie ^a   Teo, Regina ^a   Weening, Karin E ^a   Kapur, Mridu ^a   McQuillan, Karina ^a   Ryves, Jonathan ^a   Rogers, Ben ^a   Dalton, Emma ^a   Williams, Robin S B ^b   Harwood, Adrian J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL 1,4,5 TRISPHOSPHATE; INOSITOL MONOPHOSPHATASE 2; INOSITOL POLYPHOSPHATE PHOSPHATASE; LITHIUM; PHOSPHATASE; PROLYL ENDOPEPTIDASE; UNCLASSIFIED DRUG; INOSITOL; LITHIUM DERIVATIVE; MULTIPLE INOSITOL POLYPHOSPHATE PHOSPHATASE; MULTIPLE INOSITOL-POLYPHOSPHATE PHOSPHATASE;

ARTICLE; BIPOLAR DISORDER; CELL STRAIN HEK293; CHEMOTAXIS; CONTROLLED STUDY; DICTYOSTELIUM; DRUG SENSITIVITY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC REGULATION; HUMAN; HUMAN CELL; METABOLISM; NONHUMAN; SIGNAL TRANSDUCTION; BIOSYNTHESIS; DRUG EFFECT; DRUG RESISTANCE; GENETICS;

DICTYOSTELIUM;

CHEMOTAXIS; DICTYOSTELIUM; DRUG RESISTANCE; GENE EXPRESSION REGULATION; INOSITOL; LITHIUM COMPOUNDS; PHOSPHORIC MONOESTER HYDROLASES;

EID: 77956195156     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011151     Document Type: Article

References (47)

1. Craddock N, Sklar P (2009) Genetics of bipolar disorder: successful start to a long journey. Trends Genet 25: 99-105.
2. Taylor L, Faraone SV, Tsuang MT (2002) Family, twin, and adoption studies of bipolar disease. Curr Psychiatry Rep 4: 130-133.
3. Padmos RC, Van Baal GC, Vonk R, Wijkhuijs AJ, Kahn RS, et al. (2009) Genetic and environmental influences on pro-inflammatory monocytes in bipolar disorder: a twin study. Arch Gen Psychiatry 66: 957-965.
4. Alloy LB, Abramson LY, Urosevic S, Walshaw PD, Nusslock R, et al. (2005) The psychosocial context of bipolar disorder: environmental, cognitive, and developmental risk factors. Clin Psychol Rev 25: 1043-1075.
5. Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, et al. (2001) Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev. CD003013 p.
6. Atack JR, Broughton HB, Pollack SJ (1995) Structure and mechanism of inositol monophosphatase. FEBS Lett 361: 1-7.
7. Inhorn RC, Majerus PW (1988) Properties of inositol polyphosphate 1-phosphatase. J Biol Chem 263: 14559-14565.
8. Berridge MJ, Downes CP, Hanley MR (1989) Neural and developmental actions of lithium: a unifying hypothesis. Cell 59: 411-419.
9. Williams RS, Cheng L, Mudge AW, Harwood AJ (2002) A common mechanism of action for three mood-stabilizing drugs. Nature 417: 292-295.
10. Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, et al. (2005) Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 170: 1101-1111.
11. Williams RS, Eames M, Ryves WJ, Viggars J, Harwood AJ (1999) Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate. EMBO J 18: 2734-2745.
12. Maes M, De Meester I, Scharpe S, Desnyder R, Ranjan R, et al. (1996) Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs. Acta Psychiatr Scand 93: 1-8.
13. Maes M, Goossens F, Scharpe S, Calabrese J, Desnyder R, et al. (1995) Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs. Psychiatry Res 58: 217-225.
14. Breen G, Harwood AJ, Gregory K, Sinclair M, Collier D, et al. (2004) Two peptidase activities decrease in treated bipolar disorder not schizophrenic patients. Bipolar Disord 6: 156-161.
15. Schulz I, Gerhartz B, Neubauer A, Holloschi A, Heiser U, et al. (2002) Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition. Eur J Biochem 269: 5813-5820.
16. Eickholt BJ, Towers GJ, Ryves WJ, Eikel D, Adley K, et al. (2005) Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure. Mol Pharmacol 67: 1426-1433.
17. Fornai F, Longone P, Cafaro L, Kastsiuchenka O, Ferrucci M, et al. (2008) Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 105: 2052-2057.
18. Kessin RH (2001) Dictyostelium - Evolution, cell biology, and the development of multicellularity. Cambridge, UK: Cambridge Univ. Press.
19. King JS, Teo R, Ryves J, Reddy JV, Peters O, et al. (2009) The mood stabiliser lithium suppresses PIP3 signalling in Dictyostelium and human cells. Dis Model Mech 2: 306-312.
20. Otto JC, Kelly P, Chiou ST, York JD (2007) Alterations in an inositol phosphate code through synergistic activation of a G protein and inositol phosphate kinases. Proc Natl Acad Sci U S A 104: 15653-15658.
21. Cho J, King JS, Qian X, Harwood AJ, Shears SB (2008) Dephosphorylation of 2,3-bisphosphoglycerate by MIPP expands the regulatory capacity of the Rapoport-Luebering glycolytic shunt. Proc Natl Acad Sci U S A 105: 5998-6003.
22. Nalaskowski MM, Deschermeier C, Fanick W, Mayr GW (2002) The human homologue of yeast ArgRIII protein is an inositol phosphate multikinase with predominantly nuclear localization. Biochem J 366: 549-556.
23. Wilson MP, Majerus PW (1996) Isolation of inositol 1,3,4-trisphosphate 5/6-kinase, cDNA cloning and expression of the recombinant enzyme. J Biol Chem 271: 11904-11910.
24. Yang X, Shears SB (2000) Multitasking in signal transduction by a promiscuous human Ins(3,4,5,6)P(4) 1-kinase/Ins(1,3,4)P(3) 5/6-kinase. Biochem J 351 Pt 3: 551-555.
25. Steger DJ, Haswell ES, Miller AL, Wente SR, O'Shea EK (2003) Regulation of chromatin remodeling by inositol polyphosphates. Science 299: 114-116.
26. Fischbach A, Adelt S, Muller A, Vogel G (2006) Disruption of inositol biosynthesis through targeted mutagenesis in Dictyostelium discoideum - generation and characterisation of inositol-auxotrophic mutants. Biochem J 397: 509-518.
27. Loovers HM, Veenstra K, Snippe H, Pesesse X, Erneux C, et al. (2003) A diverse family of inositol 5-phosphatases playing a role in growth and development in Dictyostelium discoideum. J Biol Chem 278: 5652-5658.
28. Lax AJ (1979) The evolution of excitable behaviour in Dictyostelium. J Cell Sci 36: 311-321.
29. Gee NS, Reid GG, Jackson RG, Barnaby RJ, Ragan CI (1988) Purification and properties of inositol-1,4-bisphosphatase from bovine brain. Biochem J 253: 777-782.
30. Shen X, Xiao H, Ranallo R, Wu WH, Wu C (2003) Modulation of ATP-dependent chromatin-remodeling complexes by inositol polyphosphates. Science 299: 112-114.
31. Gao Y, Wang HY (2007) Inositol pentakisphosphate mediates Wnt/beta-catenin signaling. J Biol Chem 282: 26490-26502.
32. Mamdani F, Sequeira A, Alda M, Grof P, Rouleau G, et al. (2007) No association between the PREP gene and lithium responsive bipolar disorder. BMC Psychiatry 7: 9.
33. Van Gool AR, Van Ojik HH, Kruit WH, Mulder PG, Fekkes D, et al. (2004) Serum activity of prolyl endopeptidase, but not of dipeptidyl peptidase IV, is decreased by immunotherapy with IFN-alpha in high-risk melanoma patients. J Interferon Cytokine Res 24: 411-415.
34. Padmos RC, Hillegers MH, Knijff EM, Vonk R, Bouvy A, et al. (2008) A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry 65: 395-407.
35. Sjoholt G, Gulbrandsen AK, Lovlie R, Berle JO, Molven A, et al. (2000) A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients. Mol Psychiatry 5: 172-180.
36. Sjoholt G, Ebstein RP, Lie RT, Berle JO, Mallet J, et al. (2004) Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder. Mol Psychiatry 9: 621-629.
37. Ohnishi T, Yamada K, Ohba H, Iwayama Y, Toyota T, et al. (2007) A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription. Neuropsychopharmacology 32: 1727-1737.
38. Shaltiel G, Shamir A, Nemanov L, Yaroslavsky Y, Nemets B, et al. (2001) Inositol monophosphatase activity in brain and lymphocyte-derived cell lines of bipolar patients. World J Biol Psychiatry 2: 95-98.
39. Agam G, Shaltiel G, Kozlovsky N, Shimon H, Belmaker RH (2003) Lithium inhibitable enzymes in postmortem brain of bipolar patients. J Psychiatr Res 37: 433-442.
40. Watts DJ, Ashworth JM (1970) Growth of myxameobae of the cellular slime mould Dictyostelium discoideum in axenic culture. Biochem J 119: 171-174.
41. Zigmond SH (1988) Orientation chamber in chemotaxis. Methods Enzymol 162: 65-72.
42. Soll DR, Wessels D, Voss E, Johnson O (2001) Computer-assisted systems for the analysis of amoeboid cell motility. Methods Mol Biol 161: 45-58.
43. Van Dijken P, De Haas JR, Craxton A, Erneux C, Shears SB, et al. (1995) A novel, phospholipase C-independent pathway of inositol 1, 4,5-trisphosphate formation in Dictyostelium and rat liver. J Biol Chem 270: 29724-29731.
44. Guse AH, Goldwich A, Weber K, Mayr GW (1995) Non-radioactive, isomer-specific inositol phosphate mass determinations: high-performance liquid chromatography-micro-metal-dye detection strongly improves speed and sensitivity of analyses from cells and micro-enzyme assays. J Chromatogr B Biomed Appl 672: 189-198.
45. Casals I, Villar JL, Riera-Codina M (2002) A straightforward method for analysis of highly phosphorylated inositols in blood cells by high-performance liquid chromatography. Anal Biochem 300: 69-76.
46. Mayr GW (1988) A novel metal-dye detection system permits picomolar-range h.p.l.c. analysis of inositol polyphosphates from non-radioactively labelled cell or tissue specimens. Biochem J 254: 585-591.
47. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.